Arrivo BioVentures

Arrivo BioVentures has consistently sought solutions for unmet medical needs. We strive to become the new standard in strategic asset selection and develop innovative products through an efficient and thoughtful process. Arrivo BioVentures has established a portfolio of multiple late-stage drug candidates, each with the potential to become a first-in-class or best-in-class therapy. Novelty is not confined to just the products; our entire approach is innovative. Our unique drug development model has a proven track record of product success and superior returns. The company is built on a solid foundation, with a team that averages over 25 years of experience in drug development. Driven by insatiable curiosity and a passion for solving complex problems, we are committed to helping millions of patients worldwide.